Derivatives of andrimide and moiramide B having antibacterial properties

US7544709B2 · kind B2 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Nina Brunner · Essen, DE
• Christoph Freiberg · Wuppertal, DE
• Thomas Lampe · Mülheim an der Ruhr, DE
• Ben Newton · Warwick, GB
• Michael Otteneder · Arlesheim, CH
• Josef Pernerstorfer · Wuppertal, DE
• Jens Pohlmann · Basel, CH
• Guido Schiffer · Wuppertal, DE
• Mitsuyuki Shimada · Nara, JP

Key dates

• Filing date: Nov 7, 2002
• Grant date: Jun 9, 2009
• Expiry date: Oct 8, 2024

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P31/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to compounds of general formula (I), to a method for the production thereof, to pharmaceutical compositions containing them, and to their use in the treatment and/or prophlaxis of diseases in humans or animals, particularly bacterial infections diseases. The compounds are derivatives of the natural substances andrimide and moiramide B.